AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 50 filers reported holding AVROBIO INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $481,000 | -95.9% | 34,515 | -96.2% | 0.00% | -100.0% |
| Q3 2020 | $11,718,000 | -32.3% | 899,994 | -9.3% | 0.00% | -50.0% |
| Q2 2020 | $17,310,000 | +24.4% | 991,950 | +10.9% | 0.00% | 0.0% |
| Q1 2020 | $13,919,000 | -27.8% | 894,536 | -6.6% | 0.00% | 0.0% |
| Q4 2019 | $19,275,000 | +19.7% | 957,542 | -16.0% | 0.00% | 0.0% |
| Q3 2019 | $16,103,000 | +22.5% | 1,140,472 | +41.1% | 0.00% | 0.0% |
| Q2 2019 | $13,142,000 | -1.4% | 808,235 | +33.6% | 0.00% | 0.0% |
| Q1 2019 | $13,335,000 | -0.6% | 604,751 | -25.0% | 0.00% | 0.0% |
| Q4 2018 | $13,418,000 | -67.7% | 805,856 | +0.5% | 0.00% | -66.7% |
| Q3 2018 | $41,601,000 | +264.2% | 802,015 | +100.5% | 0.01% | +200.0% |
| Q2 2018 | $11,424,000 | – | 400,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |